Chung Hyung-min (born 1964) is a South Korean biotechnology professor.

Currently, he is a professor of biomedical science at CHA University, Director of CHA Stemcell Institute, President of CHA Bio & Diostech Inc., Member of LMO Assessment Advisory Committee for Ministry of Health and Welfare, and Advisor for the Ministry of Knowledge Economy under the National Technical Advisory Committee.

Dr Chung is a prominent leader in the field of stem cell research with over 20 years of experience.

Primarily, his study focusses on the clinical applications of human embryonic stem cell-derived retinal cells, artificial blood and cardiovascular cells.

His research group became only the second in the world to be approved[citation needed] to conduct clinical application of human embryonic stem cells for the treatment of an orphan disease named Stargardt's macular dystrophy.